학술논문

Baricitinib versus dexamethasone for adults hospitalised with COVID-19 (ACTT-4): a randomised, double-blind, double placebo-controlled trial
Document Type
Article
Author
Wolfe, Cameron RTomashek, Kay MPatterson, Thomas FGomez, Carlos AMarconi, Vincent CJain, Mamta KYang, Otto OPaules, Catharine IPalacios, Guillermo M RuizGrossberg, RobertHarkins, Michelle SMularski, Richard AErdmann, NathanielSandkovsky, UrielAlmasri, EyadPineda, Justino RegaladoDretler, Alexandra Wde Castilla, Diego LopezBranche, Angela RPark, Pauline KMehta, Aneesh KShort, William RMcLellan, Susan L FKline, SusanIovine, Nicole MEl Sahly, Hana MDoernberg, Sarah BOh, Myoung-donHuprikar, NikhilHohmann, ElizabethKelley, Colleen FHolodniy, MarkKim, Eu SukSweeney, Daniel AFinberg, Robert WGrimes, Kevin AMaves, Ryan CKo, Emily REngemann, John JTaylor, Barbara SPonce, Philip OLarson, LuAnnMelendez, Dante PaoloSeibert, Allan MRouphael, Nadine GStrebe, JoslynClark, Jesse LJulian, Kathleen Gde Leon, Alfredo PonceCardoso, Anabelade Bono, StephanieAtmar, Robert LGanesan, AnuradhaFerreira, Jennifer LGreen, MichelleMakowski, MatBonnett, TylerBeresnev, TatianaGhazaryan, VarduhiDempsey, WallaNayak, Seema UDodd, Lori EBeigel, John HKalil, Andre CWahid, LanaWalter, Emmanuel B.Belur, Akhila G.Dreyer, GracePatterson, Jan E.Bowling, Jason E.Dixon, Danielle O.Hewlett, AngelaOdrobina, RobertPupaibool, JakrapunMocherla, SatishLazarte, SuzanaCayabyab, MeilaniHussein, Rezhan H.Golamari, Reshma R.Krill, Kaleigh L.Rajme, SandraRiska, Paul F.Zingman, Barry S.Mertz, GregorySosa, NestorGoepfert, Paul A.Berhe, MezgebeDishner, EmmaFayed, MohamedHubel, KinsleyMartinez-Orozco, José ArturoBautista Felix, NoraElmor, Sammy T.Bechnak, Amer RyanSaklawi, YoussefVan Winkle, Jason W.Zea, Diego F.Laguio-Vila, MaryroseWalsh, Edward E.Falsey, Ann R.Carvajal, KarenHyzy, Robert C.Hanna, SinanOlbrich, NormanTraenkner, Jessica J.Kraft, Colleen S.Tebas, PabloBaron, Jillian TLevine, CorriNock, JoyBillings, JoanneKim, HyunElie-Turenne, Marie-CarmelleWhitaker, Jennifer A.Luetkemeyer, Anne F.Dwyer, JayBainbridge, EmmaGyun Choe, PyoengKyung Kang, ChangJilg, NikolausCantos, Valeria DBhamidipati, Divya R.Nithin Gopalsamy, SrinivasaChary, AarthiJung, JongtakSong, Kyoung-HoKim, Hong BinBenson, Constance A.McConnell, KimberlyWang, Jennifer P.Wessolossky, MireyaPerez, KatherineEubank, Taryn ABerjohn, CatherineUtz, Gregory C.Jackson, Patrick E.H.Bell, Taison D.Haughey, Heather M.Moanna, AbeerCribbs, SushmaHarrison, TelishaColombo, Christopher J.Schofield, ChristinaColombo, Rhonda E.Tapson, Victor F.Grein, JonathanSutterwala, FayyazInce, DilekWinokur, Patricia L.Fung, MonicaJang, HannahWyles, DavidFrank, Maria G.Sarcone, EllenNeumann, HenryViswanathan, AnandHochman, SarahMulligan, MarkEckhardt, BenjaminCarmody, EllieAhuja, NeeraNadeau, KariSvec, DavidMacaraeg, Jeffrey C.Morrow, LeeQuimby, DaveBessesen, MaryNicholson, LindsayAdams, JillKumar, PrincyLambert, Allison A.Arguinchona, HenryAlicic, Radica Z.Saito, ShoOhmagari, NorioMikami, AyakoChien Lye, DavidHong Lee, TauYing Chia, PoHsieh, LannyAmin, Alpesh N.Watanabe, MikiCandiotti, Keith A.Castro, Jose G.Antor, Maria A.Lee, TidaLalani, TahaniyatNovak, Richard M.Wendrow, AndreaBorgetti, Scott A.George, Sarah L.Hoft, Daniel F.Brien, James D.Cohen, Stuart H.Thompson, George R.Chakrabarty, MelonyGuirgis, FaheemDavey, Richard T.Voell, JocelynStrich, Jeffrey R.Lindholm, David A.Mende, KatrinWellington, Trevor R.Rapaka, Rekha R.Husson, Jennifer S.Levine, Andrea R.Yen Tan, SeowShafi, HumairaChien, Jaime M FHostler, David C.Hostler, Jordanna M.Shahan, Brian T.Adams, David H.Osinusi, AnuCao, HuyenBurgess, Timothy H.Rozman, JuliaChung, Kevin K.Nieuwoudt, ChristinaEl-Khorazaty, Jill A.Hill, HeatherPettibone, StephanieGettinger, NikkiEngel, TheresaLewis, TeriWang, JingDeye, Gregory A.Nomicos, EffiePikaart-Tautges, RhondaElsafy, MohamedJurao, RobertKoo, HyungProschan, MichaelYokum, TammyArega, JaniceFlorese, Ruth
Source
The Lancet Respiratory Medicine; September 2022, Vol. 10 Issue: 9 p888-899, 12p
Subject
Language
ISSN
22132600; 22132619
Abstract
Baricitinib and dexamethasone have randomised trials supporting their use for the treatment of patients with COVID-19. We assessed the combination of baricitinib plus remdesivir versus dexamethasone plus remdesivir in preventing progression to mechanical ventilation or death in hospitalised patients with COVID-19.